Comparative efficacy and safety of targeted therapy and immunotherapy for HER2-positive breast cancer: a systematic review and network meta-analyses

Overview of attention for article published in Frontiers in oncology, April 2024

Altmetric Badge

Mentioned by

twitter: 2 X users

Readers on

mendeley: 3 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 18,657 followers.

RT @FrontOncology: New research: Comparative efficacy and safety of targeted therapy and immunotherapy for HER2-positive breast cancer: a s…

03 Apr 2024

Reply Repost Favourite

New research: Comparative efficacy and safety of targeted therapy and immunotherapy for HER2-positive breast cancer: a systematic review and network meta-analyses: Background In recent years, novel therapies targeting specific molecular… https://t.co/XdOX

03 Apr 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.